The role of ubiquitylation in signaling by growth factors: Implications to cancer

Seminars in Cancer Biology

Volumn 13, Issue 1, 2003, Pages 29-40

  Shtiegman, Keren ^a   Yarden, Yosef ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Endocytosis; Growth factor; Oncogene; Signal transduction; Ubiquitin

Indexed keywords

C CB1 PROTEIN; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; HGS PROTEIN; PROTEIN DERIVATIVE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

CANCER; CANCER CELL; NONHUMAN; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; YEAST;

EID: 0037329054     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-579X(02)00097-4     Document Type: Article

References (123)

1. Yarden Y., Sliwkowski M.X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell. Biol. 2:2001;127-137.
2. Downward J., Yarden Y., Mayes E., Scrace G., Totty N., Stockwell P.et al. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature. 307:1984;521-527.
3. Guy P.M., Platko J.V., Cantley L.C., Cerione R.A., Carraway K.L. Insect cell-expressed p180ErbB3 possesses an impaired tyrosine kinase activity. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8132-8136.
4. Yarden Y., Schlessinger J. Epidermal growth factor induce rapid, reversible aggregation of purified epidermal growth factor receptor. Biochemistry. 26:1987;1443-1445.
5. Graus Porta D., Beerli R.R., Daly J.M., Hynes N.E. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J. 16:1997;1647-1655.
6. Tzahar E., Waterman H., Chen X., Levkowitz G., Karunagaran D., Lavi S.et al. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor. Mol. Cell. Biol. 16:1996;5276-5287.
7. Perrimon N., Perkins L.A. There must be 50 ways to rule the signal: the case of the Drosophila EGF receptor. Cell. 89:1997;13-16.
8. Jongeward G.D., Clandinin T.R., Sternberg P.W. sli-1, a negative regulator of let-23-mediated signaling in C. elegans. Genetics. 139:1995;1553-1566.
9. Hajnal A., Whitfield C.W., Kim S.K. Inhibition of Caenorhabditis elegans vulval induction by gap-1 and by let-23 receptor tyrosine kinase. Genes Dev. 11:1997;2715-2728.
10. Hopper N.A., Lee J., Sternberg P.W. ARK-1 inhibits EGFR signaling in C. elegans. Mol. Cell. 6:2000;65-75.
11. Jin M.H., Sawamoto K., Ito M., Okano H. The interaction between the Drosophila secreted protein argos and the epidermal growth factor receptor inhibits dimerization of the receptor and binding of secreted spitz to the receptor. Mol. Cell. Biol. 20:2000;2098-2107.
12. Ghiglione C., Carraway K.L., Amundadottir L.T., Boswell R.E., Perrimon N., Duffy J.B. The transmembrane molecule kekkon 1 acts in a feedback loop to negatively regulate the activity of the Drosophila EGF receptor during oogenesis. Cell. 96:1999;847-856.
13. Casci T., Vinos J., Freeman M. Sprouty, an intracellular inhibitor of Ras signaling. Cell. 96:1999;655-665.
14. Basu A., Raghunath M., Bishayee S., Das M. Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation. Mol. Cell. Biol. 9:1989;671-677.
15. Fiorentino L., Pertica C., Fiorini M., Talora C., Crescenzi M., Castellani L.et al. Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain. Mol. Cell. Biol. 20:2000;7735-7750.
16. Wells A., Welsh J.B., Lazar C.S., Wiley H.S., Gill G.N., Rosenfeld M.G. Ligand-induced transformation by a non-internalizing epidermal growth factor receptor. Science. 247:1990;962-964.
17. Lenferink A.E., Pinkas Kramarski R., van de Poll M.L., van Vugt M.J., Klapper L.N., Tzahar E.et al. Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers. EMBO J. 17:1998;3385-3397.
18. Waterman H., Sabanai I., Geiger B., Yarden Y. Alternative intracellular routing of ErbB receptors may determine signaling potency. J. Biol. Chem. 273:1998;13819-13827.
19. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
20. Burke P., Schooler K., Wiley H.S. Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. Mol. Biol. Cell. 12:2001;1897-1910.
21. Brodsky F.M., Chen C.Y., Knuehl C., Towler M.C., Wakeham D.E. Biological basket weaving: formation and function of clathrin-coated vesicles. Annu. Rev. Cell. Dev. Biol. 17:2001;517-568.
22. Warren R.A., Green F.A., Enns C.A. Saturation of the endocytic pathway for the transferrin receptor does not affect the endocytosis of the epidermal growth factor receptor. J. Biol. Chem. 272:1997;2116-2121.
23. Nesterov A., Wiley H.S., Gill G.N. Ligand-induced endocytosis of epidermal growth factor receptors that are defective in binding adaptor proteins. Proc. Natl. Acad. Sci. U.S.A. 92:1995;8719-8723.
24. Nesterov A., Carter R.E., Sorkina T., Gill G.N., Sorkin A. Inhibition of the receptor-binding function of clathrin adaptor protein AP-2 by dominant-negative mutant mu2 subunit and its effects on endocytosis. EMBO J. 18:1999;2489-2499.
25. Lehrman M.A., Goldstein J.L., Brown M.S., Russell D.W., Schneider W.J. Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain. Cell. 41:1985;735-743.
26. Heilker R., Spiess M., Crottet P. Recognition of sorting signals by clathrin adaptors. Bioessays. 21:1999;558-567.
27. Levkowitz G., Waterman H., Zamir E., Kam Z., Oved S., Langdon W.Y.et al. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 12:1998;3663-3674.
28. Waterman H., Levkowitz G., Alroy I., Yarden Y. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor. J. Biol. Chem. 274:1999;22151-22154.
29. Levkowitz G., Waterman H., Ettenberg S.A., Katz M., Tsygankov A.Y., Alroy I.et al. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol. Cell. 4:1999;1029-1040.
30. Joazeiro C.A., Wing S.S., Huang H., Leverson J.D., Hunter T., Liu Y.C. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science. 286:1999;309-312.
31. Yokouchi M., Kondo T., Houghton A., Bartkiewicz M., Horne W.C., Zhang H.et al. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7. J. Biol. Chem. 274:1999;31707-31712.
32. Lamaze C., Schmid S.L. Recruitment of epidermal growth factor receptors into coated pits requires their activated tyrosine kinase. J. Cell. Biol. 129:1995;47-54.
33. Wilde A., Beattie E.C., Lem L., Riethof D.A., Liu S.-H., Mobley W.C.et al. EGF receptor signaling stimulates Src kinase phosphorylation of clathrin, influencing clathrin redistribution and EGF uptake. Cell. 96:1999;677-687.
34. Fazioli F., Bottaro D.P., Minichiello L., Auricchio A., Wong W.T., Segatto O.et al. Identification and biochemical characterization of novel putative substrates for the epidermal growth factor receptor kinase. J. Biol. Chem. 267:1992;5155-5161.
35. Salcini A.E., Confalonieri S., Doria M., Santolini E., Tassi E., Minenkova O.et al. Binding specificity and in vivo targets of the EH domain, a novel protein-protein interaction module. Genes Dev. 11:1997;2239-2249.
36. Mayer B.J. Endocytosis: EH domains lend a hand. Curr. Biol. 9:1999;R70-R73.
37. Paoluzi S., Castagnoli L., Lauro I., Salcini A.E., Coda L., Fre S.et al. Recognition specificity of individual EH domains of mammals and yeast. EMBO J. 17:1998;6541-6550.
38. Tebar F., Confalonieri S., Carter R.E., Di Fiore P.P., Sorkin A. Eps15 is constitutively oligomerized due to homophilic interaction of its coiled-coil region. J. Biol. Chem. 272:1997;15413-15418.
39. Benmerah A., Begue B., Dautry Varsat A., Cerf Bensussan N. The ear of alpha-adaptin interacts with the COOH-terminal domain of the Eps 15 protein. J. Biol. Chem. 271:1996;12111-12116.
40. Vecchi M., Polo S., Poupon V., van de Loo J.W., Benmerah A., Di Fiore P.P. Nucleocytoplasmic shuttling of endocytic proteins. J. Cell. Biol. 153:2001;1511-1517.
41. Torrisi M.R., Lotti L.V., Belleudi F., Gradini R., Salcini A.E., Confalonieri S.et al. Eps15 is recruited to the plasma membrane upon epidermal growth factor receptor activation and localizes to components of the endocytic pathway during receptor internalization. Mol. Biol. Cell. 10:1999;417-434.
42. Benmerah A., Lamaze C., Begue B., Schmid S.L., Dautry Varsat A., Cerf Bensussan N. AP-2/Eps15 interaction is required for receptor-mediated endocytosis. J. Cell. Biol. 140:1998;1055-1062.
43. Carbone R., Fre S., Iannolo G., Belleudi F., Mancini P., Pelicci P.G.et al. eps15 and eps15R are essential components of the endocytic pathway. Cancer Res. 57:1997;5498-5504.
44. Confalonieri S., Salcini A.E., Puri C., Tacchetti C., Di Fiore P.P. Tyrosine phosphorylation of Eps15 is required for ligand-regulated, but not constitutive, endocytosis. J. Cell. Biol. 150:2000;905-912.
45. van Delft S., Govers R., Strous G.J., Verkleij A.J., van Bergen en Henegouwen P.M. Epidermal growth factor induces ubiquitination of Eps15. J. Biol. Chem. 272:1997;14013-14016.
46. Komada M., Kitamura N. Growth factor-induced tyrosine phosphorylation of Hrs, a novel 115-kilodalton protein with a structurally conserved putative zinc finger domain. Mol. Cell. Biol. 15:1995;6213-6221.
47. Steen H., Kuster B., Fernandez M., Pandey A., Mann M. Tyrosine phosphorylation mapping of the epidermal growth factor receptor signaling pathway. J. Biol. Chem. 277:2002;1031-1039.
48. Komada M., Kitamura N. Hrs and hbp: possible regulators of endocytosis and exocytosis. Biochem. Biophys. Res. Commun. 281:2001;1065-1069.
49. Stenmark H., Aasland R. FYVE-finger proteins-effector of an inositol lipid. J. Cell. Sci. 112:1999;4175-4183.
50. Hayakawa A., Kitamura N. Early endosomal localization of hrs requires a sequence within the proline- and glutamine-rich region but not the FYVE finger. J. Biol. Chem. 275:2000;29636-29642.
51. Chin L.S., Raynor M.C., Wei X., Chen H.Q., Li L. Hrs interacts with sorting nexin 1 and regulates degradation of epidermal growth factor receptor. J. Biol. Chem. 276:2001;7069-7078.
52. Asao H., Sasaki Y., Arita T., Tanaka N., Endo K., Kasai H.et al. a signal-transducing adaptor molecule. Its suppressive effect on cytokine-induced cell growth. J. Biol. Chem. 272:1997;32785-32791.
53. Lohi O., Poussu A., Merilainen J., Kellokumpu S., Wasenius V.M., Lehto V.P. EAST, an epidermal growth factor receptor- and Eps15-associated protein with Src homology 3 and tyrosine-based activation motif domains. J. Biol. Chem. 273:1998;21408-21415.
54. Takata H., Kato M., Denda K., Kitamura N. A hrs binding protein having a Src homology 3 domain is involved in intracellular degradation of growth factors and their receptors. Genes Cells. 5:2000;57-69.
55. Kato M., Miyazawa K., Kitamura N. A deubiquitinating enzyme UBPY interacts with the Src homology 3 domain of Hrs-binding protein via a novel binding motif PX(V/I)(D/N)RXXKP. J. Biol. Chem. 275:2000;37481-37487.
56. Piper R.C., Cooper A.A., Yang H., Stevens T.H. VPS27 controls vacuolar and endocytic traffic through a prevacuolar compartment in Saccharomyces cerevisiae. J. Cell. Biol. 131:1995;603-617.
57. Komada M., Soriano P. Hrs, a FYVE finger protein localized to early endosomes, is implicated in vesicular traffic and required for ventral folding morphogenesis. Genes Dev. 13:1999;1475-1485.
58. Tsujimoto S., Pelto-Huikko M., Aitola M., Meister B., Vik-Mo E.O., Davanger S.et al. The cellular and developmental expression of hrs-2 in rat. Eur. J. Neurosci. 11:1999;3047-3063.
59. Urbe S., Mills I.G., Stenmark H., Kitamura N., Clague M.J. Endosomal localization and receptor dynamics determine tyrosine phosphorylation of hepatocyte growth factor-regulated tyrosine kinase substrate. Mol. Cell. Biol. 20:2000;7685-7692.
60. Lloyd T.E., Atkinson R., Wu M.N., Zhou Y., Pennetta G., Bellen H.J. Hrs regulates endosome membrane invagination and tyrosine kinase receptor signaling in Drosophila. Cell. 108:2002;261-269.
61. Raiborg C., Bach K.G., Mehlum A., Stang E., Stenmark H. Hrs recruits clathrin to early endosomes. EMBO J. 20:2001;5008-5021.
62. Bean A.J., Davanger S., Chou M.F., Gerhardt B., Tsujimoto S., Chang Y. Hrs-2 regulates receptor-mediated endocytosis via interactions with Eps15. J. Biol. Chem. 275:2000;15271-15278.
63. Yeung B.G., Phan H.L., Payne G.S. Adaptor complex-independent clathrin function in yeast. Mol. Biol. Cell. 10:1999;3643-3659.
64. Rohrer J., Benedetti H., Zanolari B., Riezman H. Identification of a novel sequence mediating regulated endocytosis of the G protein-coupled alpha-pheromone receptor in yeast. Mol. Biol. Cell. 4:1993;511-521.
65. Roth A.F., Sullivan D.M., Davis N.G. A large PEST-like sequence directs the ubiquitination, endocytosis, and vacuolar degradation of the yeast a-factor receptor. J. Cell Biol. 142:1998;949-961.
66. Tan P.K., Howard J.P., Payne G.S. The sequence NPFXD defines a new class of endocytosis signal in Saccharomyces cerevisiae. J. Cell. Biol. 135:1996;1789-1800.
67. Hicke L., Zanolari B., Riezman H. Cytoplasmic tail phosphorylation of the alpha-factor receptor is required for its ubiquitination and internalization. J. Cell. Biol. 141:1998;349-358.
68. Hicke L., Riezman H. Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulated endocytosis. Cell. 84:1996;277-287.
69. Shih S.C., Sloper-Mould K.E., Hicke L. Monoubiquitin carries a novel internalization signal that is appended to activated receptors. EMBO J. 19:2000;187-198.
70. Sloper-Mould K.E., Jemc J.C., Pickart C.M., Hicke L. Distinct functional surface regions on ubiquitin. J. Biol. Chem. 8:2001;8.
71. Roth A.F., Davis N.G. Ubiquitination of the PEST-like endocytosis signal of the yeast a-factor receptor. J. Biol. Chem. 275:2000;8143-8153.
72. Chen L., Davis N.G. Recycling of the yeast a-factor receptor. J. Cell. Biol. 151:2000;731-738.
73. Hershko A., Ciechanover A. The ubiquitin system. Ann. Rev. Biochem. 67:1998;425-479.
74. Langdon W.Y., Hartley J.W., Klinken S.P., Ruscetti S.K., Morse H.D. v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. Proc. Natl. Acad. Sci. U.S.A. 86:1989;1168-1172.
75. Yoon C.H., Lee J., Jongeward G.D., Sternberg P.W. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-Cbl. Science. 269:1995;1102-1105.
76. Meisner H., Daga A., Buxton J., Fernandez B., Chawla A., Banerjee U.et al. Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development. Mol. Cell. Biol. 17:1997;2217-2225.
77. Pai L.M., Barcelo G., Schupbach T. D-cbl, a negative regulator of the Egfr pathway, is required for dorsoventral patterning in Drosophila oogenesis. Cell. 103:2000;51-61.
78. Thien C.B., Langdon W.Y. Cbl: many adaptations to regulate protein tyrosine kinases. Nat. Rev. Mol. Cell. Biol. 2:2001;294-307.
79. Thien C.B., Walker F., Langdon W.Y. RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation. Mol. Cell. 7:2001;355-365.
80. Wong E.S., Lim J., Low B.C., Chen Q., Guy G.R. Evidence for direct interaction between Sprouty and Cbl. J. Biol. Chem. 276:2001;5866-5875.
81. Feshchenko E.A., Langdon W.Y., Tsygankov A.Y. Fyn, Yes, and Syk phosphorylation sites in c-Cbl map to the same tyrosine residues that become phosphorylated in activated T cells. J. Biol. Chem. 273:1998;8323-8331.
82. Tsygankov A.Y., Teckchandani A.M., Feshchenko E.A., Swaminathan G. Beyond the RING: CBL proteins as multivalent adapters. Oncogene. 20:2001;6382-6402.
83. Tanaka S., Amling M., Neff L., Peyman A., Uhlmann E., Levy J.B.et al. c-Cbl is downstream of c-Src in a signaling pathway necessary for bone resorption. Nature. 383:1996;528-531.
84. Sanjay A., Houghton A., Neff L., DiDomenico E., Bardelay C., Antoine E.et al. Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J. Cell. Biol. 152:2001;181-195.
85. Thien C.B., Langdon W.Y. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene. Oncogene. 14:1997;2239-2249.
86. Miyake S., Mullane-Robinson K.P., Lill N.L., Douillard P., Band H. Cbl-mediated negative regulation of platelet-derived growth factor receptor-dependent cell proliferation. A critical role for Cbl tyrosine kinase-binding domain. J. Biol. Chem. 274:1999;16619-16628.
87. Lee P.S., Wang Y., Dominguez M.G., Yeung Y.G., Murphy M.A., Bowtell D.D.et al. The cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation, and attenuates macrophage proliferation. EMBO J. 18:1999;3616-3628.
88. Klapper L.N., Waterman H., Sela M., Yarden Y. Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2. Cancer Res. 60:2000;3384-3388.
89. Levkowitz G., Oved S., Klapper L.N., Harari D., Lavi S., Sela M.et al. c-Cbl is a suppressor of the neu oncogene. J. Biol. Chem. 275:2000;35532-35539.
90. Peschard P., Fournier T.M., Lamorte L., Naujokas M.A., Band H., Langdon W.Y.et al. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol. Cell. 8:2001;995-1004.
91. Wilhelmsen K., Burkhalter S., van der Geer P. C-Cbl binds the CSF-1 receptor at tyrosine 973, a novel phosphorylation site in the receptor's carboxy-terminus. Oncogene. 21:2002;1079-1089.
92. Waterman H., Katz M., Rubin C., Shtiegman K., Lavi S., Elson A.et al. A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling. EMBO J. 21:2002;303-313.
93. Stang E., Johannessen L.E., Knardal S.L., Madshus I.H. Polyubiquitination of the epidermal growth factor receptor occurs at the plasma membrane upon ligand-induced activation. J. Biol. Chem. 275:2000;13940-13947.
94. de Melker A.A., van der Horst G., Calafat J., Jansen H., Borst J. c-Cbl ubiquitinates the EGF receptor at the plasma membrane and remains receptor associated throughout the endocytic route. J. Cell Sci. 114:2001;2167-2178.
95. Hicke L. Protein regulation by monoubiquitin. Nat. Rev. Mol. Cell. Biol. 2:2001;195-201.
96. Lai E.C., Deblandre G.A., Kintner C., Rubin G.M. Drosophila neuralized is a ubiquitin ligase that promotes the internalization and degradation of delta. Dev. Cell. 1:2001;783-794.
97. Parks A.L., Klueg K.M., Stout J.R., Muskavitch M.A. Ligand endocytosis drives receptor dissociation and activation in the Notch pathway. Development. 127:2000;1373-1385.
98. Pavlopoulos E., Pitsouli C., Klueg K.M., Muskavitch M.A., Moschonas N.K., Delidakis C. Neuralized encodes a peripheral membrane protein involved in delta signaling and endocytosis. Dev. Cell. 1:2001;807-816.
99. Buttner C., Sadtler S., Leyendecker A., Laube B., Griffon N., Betz H.et al. Ubiquitination precedes internalization and proteolytic cleavage of plasma membrane-bound glycine receptors. J. Biol. Chem. 276:2001;42978-42985.
100. Wang Y., Yeung Y.G., Langdon W.Y., Stanley E.R. c-Cbl is transiently tyrosine-phosphorylated, ubiquitinated, and membrane-targeted following CSF-1 stimulation of macrophages. J. Biol. Chem. 271:1996;17-20.
101. Wang Y., Yeung Y.G., Stanley E.R. CSF-1 stimulated multiubiquitination of the CSF-1 receptor and of Cbl follows their tyrosine phosphorylation and association with other signaling proteins. J. Cell. Biochem. 72:1999;119-134.
102. Staub O., Gautschi I., Ishikawa T., Breitschopf K., Ciechanover A., Schild L.et al. Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination. EMBO J. 16:1997;6325-6336.
103. Nakatsu F., Sakuma M., Matsuo Y., Arase H., Yamasaki S., Nakamura N.et al. A Di-leucine signal in the ubiquitin moiety. Possible involvement in ubiquitination-mediated endocytosis. J. Biol. Chem. 275:2000;26213-26219.
104. Hofmann K., Bucher P. The UBA domain: a sequence motif present in multiple enzyme classes of the ubiquitination pathway. Trends Biochem. Sci. 21:1996;172-173.
105. Bertolaet B.L., Clarke D.J., Wolff M., Watson M.H., Henze M., Divita G.et al. UBA domains of DNA damage-inducible proteins interact with ubiquitin. Nat. Struct. Biol. 8:2001;417-422.
106. Chen L., Shinde U., Ortolan T.G., Madura K. Ubiquitin-associated (UBA) domains in Rad23 bind ubiquitin and promote inhibition of multi-ubiquitin chain assembly. EMBO Rep. 2:2001;933-938.
107. Rao H., Sastry A. Recognition of specific ubiquitin conjugates is important for the proteolytic functions of the UBA domain proteins Dsk2 and Rad23. J. Biol. Chem. 227:2002;11691-11695.
108. Wilkinson C.R., Seeger M., Hartmann-Petersen R., Stone M., Wallace M., Semple C.et al. Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. Nat. Cell. Biol. 3:2001;939-943.
109. Bartkiewicz M., Houghton A., Baron R. Leucine zipper-mediated homodimerization of the adaptor protein c-Cbl. A role in c-Cbl's tyrosine phosphorylation and its association with epidermal growth factor receptor. J. Biol. Chem. 274:1999;30887-30895.
110. Hoffman K., Falquetb L. A ubiquitin-interacting motif conserved in components of the proteasomal and lysosomal protein degradation systems. Trends Biochem. Sci. 26:2001;347-350.
111. Deveraux Q., Ustrell V., Pickart C., Rechsteiner M. A 26 S protease subunit that binds ubiquitin conjugates. J. Biol. Chem. 269:1994;7059-7061.
112. Fu H., Sadis S., Rubin D.M., Glickman M., van Nocker S., Finley D.et al. Multiubiquitin chain binding and protein degradation are mediated by distinct domains within the 26 S proteasome subunit Mcb1. J. Biol. Chem. 273:1998;1970-1981.
113. Rocca A., Lamaze C., Subtil A., Dautry-Varsat A. Involvement of the ubiquitin/proteasome system in sorting of the interleukin 2 receptor beta chain to late endocytic compartments. Mol. Biol. Cell. 12:2001;1293-1301.
114. Reggiori F., Pelham H.R. Sorting of proteins into multivesicular bodies: ubiquitin-dependent and -independent targeting. EMBO J. 20:2001;5176-5186.
115. Katzmann D.J., Babst M., Emr S.D. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex. ESCRT-I Cell. 106:2001;145-155.
116. Babst M., Odorizzi G., Estepa E.J., Emr S.D. Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic. 1:2000;248-258.
117. Govers R., ten Broeke T., van Kerkhof P., Schwartz A.L., Strous G.J. Identification of a novel ubiquitin conjugation motif, required for ligand-induced internalization of the growth hormone receptor. EMBO J. 18:1999;28-36.
118. Wendland B., Emr S.D. Pan1p, yeast eps15, functions as a multivalent adaptor that coordinates protein-protein interactions essential for endocytosis. J. Cell. Biol. 141:1998;71-84.
119. Springael J.Y., De Craene J.O., Andre B. The yeast Npi1/Rsp5 ubiquitin ligase lacking its N-terminal C2 domain is competent for ubiquitination but not for subsequent endocytosis of the gap1 permease. Biochem. Biophys. Res. Commun. 257:1999;561-566.
120. Dunn R., Hicke L. Multiple roles for Rsp5p-dependent ubiquitination at the internalization step of endocytosis. J. Biol. Chem. 276:2001;25974-25981.
121. Chen X., Zhang B., Fischer J.A. A specific protein substrate for a deubiquitinating enzyme: liquid facets is the substrate of fat facets. Genes Dev. 16:2002;289-294.
122. Shenoy S.K., McDonald P.H., Kohout T.A., Lefkowitz R.J. Regulation of receptor fate by ubiquitination of activated beta 2- adrenergic receptor and beta-arrestin. Science. 294:2001;1307-1313.
123. Cadavid A.L., Ginzel A., Fischer J.A. The function of the Drosophila fat facets deubiquitinating enzyme in limiting photoreceptor cell number is intimately associated with endocytosis. Development. 127:2000;1727-1736.